Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report

Antonio Cuneo, Lydia Scarfò, Gianluigi Reda, Marzia Varettoni, Francesca Maria Quaglia, Monia Marchetti, Lorenzo De Paoli, Francesca Re, Daniela Pietrasanta, Gian Matteo Rigolin, Lorella Orsucci, Adalberto Ibatici, Valter Gattei, Francesca R. Mauro, Livio Trentin, Luca Laurenti, Roberto Marasca, Robin Foà

Blood (2020) 136 (6): 763–766.

https://doi.org/10.1182/blood.2020006854

Published: 2020

Journal Articles

Age Is Not a Predictive Marker in Molecularly Annotated Elderly Patients with Myelofibrosis Treated with Ruxolitinib: a Multicenter Study on 277 Patients.

Blood (2017) 130 (Supplement 1): 1642.

https://doi.org/10.1182/blood.V130.Suppl_1.1642.1642

Published: 2017

Journal Articles

Impact of Ruxolitinib-Response Feature on Outcome in Myelofibrosis: A Multicentre Study on 356 Patients

Blood (2017) 130 (Supplement 1): 1639.

https://doi.org/10.1182/blood.V130.Suppl_1.1639.1639

Published: 2017

Journal Articles

Efficacy and Safety of Ruxolitinib in Elderly Patients (> 75 years) with Myelofibrosis

Blood (2016) 128 (22): 4251.

https://doi.org/10.1182/blood.V128.22.4251.4251

Published: 2016

Journal Articles

Predictors for Response to Ruxolitinib in Real-Life: An Observational Independent Study on 408 Patients with Myelofibrosis

Blood (2016) 128 (22): 1128.

https://doi.org/10.1182/blood.V128.22.1128.1128

Published: 2016

Journal Articles

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

Anna Maria Raiola, MD, Sara Aquino, MD, Germana Beltrami, MD, Stefania Bregante, MD, Fabio Cruciani, MD, Carmen Di Grazia, MD, Alida Dominietto, MD, Anna Ghiso, MD, Francesca Gualandi, MD, Adalberto Ibatici, MD, Teresa Lamparelli, MD, Carlo Marani, MD, Maria Teresa van Lint, MD, Riccardo Varaldo, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD

Blood (2016) 128 (22): 3173.

https://doi.org/10.1182/blood.V128.22.3173.3173

Published: 2016

Journal Articles

High Predictive Value of Pre Transplant Minimal Residual Disease Assessment By Combining WT1 Expression and Flow Cytometry in Acute Myeloid Leukemia

Fabio Guolo, MD, Federica Galaverna, MD, Paola Minetto, MD, Livia Giannoni, MD, Chiara Ghiggi, PhD, Marino Clavio, MD, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Adalberto Ibatici, MD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 2029.

https://doi.org/10.1182/blood.V126.23.2029.2029

Published: 2015

Journal Articles

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Carmen Di Grazia, MD, Simona Geroldi, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Nicoletta Colombo, PhD, Elisabetta Tedone, Silvia Luchetti, Teresa Lamparelli, Francesca Gualandi, MD, Adalberto Ibatici, MD, Stefania Bregante, Maria Teresa van Lint, Anna Maria Raiola, Alida Dominietto, MD, Riccardo Varaldo, Federica Galaverna, Anna Ghiso, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 1866.

https://doi.org/10.1182/blood.V126.23.1866.1866

Published: 2015

Journal Articles

Panobinostat As Salvage Treatment for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible to High Dose Therapy: A Phase II Study of the Fondazione Italiana Linfomi (FIL)

Francesco Zaja, Stefano Volpetti, Annalisa Chiappella, MD, Flavia Salvi, MD, Angelo M. Carella, Adalberto Ibatici, Pier Paolo Piccaluga, Stefano A. Pileri, Davide Rossi, MD PhD, Pier Luigi Zinzani, Caterina Patti, Umberto Vitolo, Alfonso D'Arco, Alessandra Tucci, Silvia Franceschetti, Andrea Evangelista, Valentina Lenti, Renato Fanin, Alessandro Levis

Blood (2014) 124 (21): 1755.

https://doi.org/10.1182/blood.V124.21.1755.1755

Published: 2014

Journal Articles

Long-Term Results Of Allogeneic Stem Cell Transplantation In 56 Adult Patients With Philadelphia-Positive Acute Lymphoblastic Leukemia: A 20-Year Single Center Experience

Adalberto Ibatici, MD, Fabio Guolo, MD, Federica Galaverna, Clara Delle Piane, MD, Alida Dominietto, Anna Maria Raiola, Maria Teresa van Lint, MD, Carmen Di Grazia, MD, Angelo Michele Carella, Andrea Bacigalupo, MD

Blood (2013) 122 (21): 5521.

https://doi.org/10.1182/blood.V122.21.5521.5521

Published: 2013

Journal Articles

Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT

Sebastian Giebel, MD, Myriam Labopin, MD, Adalberto Ibatici, MD, Paul Browne, MD, Tomasz Czerw, Gérard Socié, MD, PhD, Ali Unal, MD, Slawomira Kyrcz-Krzemien, MD, Andrea Bacigalupo, MD, Hakan Goker, MD, Michael N Potter, MBBS, PhD, Grant McQuaker, MD, Dietrich Beelen, MD, Noel Milpied, MD, PhD, Antonio Campos, MD, Charles Craddock, MD DPhil, Mohamad Mohty, MD, PhD

Blood (2013) 122 (21): 2150.

https://doi.org/10.1182/blood.V122.21.2150.2150

Published: 2013

Journal Articles

In Vitro Preclinical Study Results for a Phase I Adoptive Immunotherapy Trial Using Cetuximab in Association with Allogeneic NK Cell Infusion in KRAS Oncogene Mutated Metastatic Colorectal Cancer Patients.

Elisabetta Todisco, Francesca Re, Donatella Genovese, Ilaria Turin, Lorenza Rimassa, Adalberto Ibatici, Luca Castagna, Armando Santoro, Daniela Montagna

Blood (2009) 114 (22): 5119.

https://doi.org/10.1182/blood.V114.22.5119.5119

Published: 2009

Journal Articles

Direct Intra-Bone Cord-Blood Transplantation Overcomes the Problem of Graft Failure Even When Low Numbers of HLA-Mismatched Cord- Blood Cells Are Transplanted, Thus Leading to the Possibility of Use of This Technique in a Large Number of Patients.

Francesco Frassoni, MD, Franca Fagioli, MD, Marina Podestà, BiolSci, Francesca Gualandi, MD, Massimo Berger, MD, Francesca Nesi, MD, Annamaria Raiola, MD, Adalberto Ibatici, MD, Marco Gobbi, MD, Myriam Labopin, MD, Andrea Bacigalupo, MD

Blood (2008) 112 (11): 1961.

https://doi.org/10.1182/blood.V112.11.1961.1961

Published: 2008

Journal Articles

Rituximab Prophylaxis of EBV Reactivation after Alternative Donor Transplants Following Anti-Thymocyte Globulin-Based Conditioning Regimens.

Andrea Bacigalupo, MD, Alida Dominietto, Monica Soracco, Anna Maria Raiola, Maria Teresa Van Lint, Teresa Lamparelli, Adalberto Ibatici, Francesca Gualandi, Francesco Frassoni, Elisabetta Tedone

Blood (2008) 112 (11): 2232.

https://doi.org/10.1182/blood.V112.11.2232.2232

Published: 2008

Journal Articles

Direct Intra-Bone Injection of Unrelated Cord Blood Cells Overcomes the Problem of Delayed Engraftment and Improves the Feasibility of Hematopoietic Transplant in Adult Patients.

Adalberto Ibatici, MD, AnnaMaria Raiola, MD, Marina Podesta, BSC, Francesca Gualandi, MD, Nadia Sessarego, BSC, Alessia Parodi, BSC, Silvia Luchetti, BSC, Sarah Pozzi, BSC, Valeria Pinto, MD, Giovanna Piaggio, BSC, Marco Gobbi, MD, Andrea Bacigalupo, MD, Francesco Frassoni, MD

Blood (2007) 110 (11): 334.

https://doi.org/10.1182/blood.V110.11.334.334

Published: 2007

Journal Articles

Compared Molecular Monitoring of BCR-ABL Transcripts in Peripheral Blood and Bone Marrow Samples in CML Patients after Allogeneic Hematopoiteic Stem Cell Transplant.

Alida Dominietto, MD, Gabriella Cirmena, Anna Garuti, Anna Maria Raiola, MD, Adalberto Ibatici, MD, Maria Teresa van Lint, MD, Francesco Frassoni, MD, Andrea Bacigalupo, MD

Blood (2006) 108 (11): 5339.

https://doi.org/10.1182/blood.V108.11.5339.5339

Published: 2006

Journal Articles

Direct Intra-Bone Marrow Transplant of Cord Blood Cells: A Way To Overcome Delayed Engraftment.

Adalberto Ibatici, Anna Maria Raiola, Marina Podesta, Sarah Pozzi, Silvia Lucchetti, Lucia Casarino, Domenico Occhini, Maria Teresa van Lint, Francesca Gualandi, Francesco Gamaleri, Andrea Bacigalupo, Francesco Frassoni

Blood (2006) 108 (11): 3190.

https://doi.org/10.1182/blood.V108.11.3190.3190

Published: 2006

Journal Articles

Molecular Responders (<3-log Reduction) among CML Patients in Complete Cytogenetic Remission Show a Lower Number of BCR-ABL+ Hematopoietic Progenitors Compared to Non-Responders.

Adalberto Ibatici, Giusy Fugazza, Nadia Sessarego, Marina Podesta, Stefania Agliano, Sarah Pozzi, Mirko Corselli, Anna Garuti, Mario Sessarego, Francesco Frassoni

Blood (2005) 106 (11): 4325.

https://doi.org/10.1182/blood.V106.11.4325.4325

Published: 2005

Journal Articles

Rituximab Prophylaxis of EBV Reactivation after Unrelated Donor Transplants Using Anti-Thymocyte Globulin in the Conditioning Regimen.

Andrea Bacigalupo, MD, Alida Dominietto, MD, Monica Soracco, MD, Sarah Pozzi, MD, Anna Maria Raiola, MD, Maria Teresa van Lint, MD, Teresa Lamparelli, MD, Adalberto Ibatici, MD, Francesco Frassoni, MD, Elisabetta Tedone, MD

Blood (2005) 106 (11): 3231.

https://doi.org/10.1182/blood.V106.11.3231.3231

Published: 2005

Journal Articles

The Persistence of p190 BCR-ABL Transcripts Is Associated with Lower Probability of Molecular Response to Imatinib in Early and Late Chronic Phase CML Patients.

Anna Garuti, PhD, Adalberto Ibatici, MD, Gabriella Cirmena, PhD, Maurizio Miglino, MD, Riccardo Varaldo, MD, Colombo Nicoletta, PhD, Roberta Grasso, PhD, Sarah Pozzi, PhD, Marina Podesta, PhD, Marco Gobbi, MD, Mario Sessarego, MD, Franco Patrone, MD, Francesco Frassoni, MD

Blood (2005) 106 (11): 3282.

https://doi.org/10.1182/blood.V106.11.3282.3282

Published: 2005

NARROW

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report

Age Is Not a Predictive Marker in Molecularly Annotated Elderly Patients with Myelofibrosis Treated with Ruxolitinib: a Multicenter Study on 277 Patients.

Impact of Ruxolitinib-Response Feature on Outcome in Myelofibrosis: A Multicentre Study on 356 Patients

Efficacy and Safety of Ruxolitinib in Elderly Patients (> 75 years) with Myelofibrosis

Predictors for Response to Ruxolitinib in Real-Life: An Observational Independent Study on 408 Patients with Myelofibrosis

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

High Predictive Value of Pre Transplant Minimal Residual Disease Assessment By Combining WT1 Expression and Flow Cytometry in Acute Myeloid Leukemia

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Panobinostat As Salvage Treatment for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible to High Dose Therapy: A Phase II Study of the Fondazione Italiana Linfomi (FIL)

Long-Term Results Of Allogeneic Stem Cell Transplantation In 56 Adult Patients With Philadelphia-Positive Acute Lymphoblastic Leukemia: A 20-Year Single Center Experience

Association Of Health Care Expenditure With Results Of Allogeneic HSCT For Adults With ALL: An Analysis From Acute Leukemia Working Party Of The EBMT

In Vitro Preclinical Study Results for a Phase I Adoptive Immunotherapy Trial Using Cetuximab in Association with Allogeneic NK Cell Infusion in KRAS Oncogene Mutated Metastatic Colorectal Cancer Patients.

Direct Intra-Bone Cord-Blood Transplantation Overcomes the Problem of Graft Failure Even When Low Numbers of HLA-Mismatched Cord- Blood Cells Are Transplanted, Thus Leading to the Possibility of Use of This Technique in a Large Number of Patients.

Rituximab Prophylaxis of EBV Reactivation after Alternative Donor Transplants Following Anti-Thymocyte Globulin-Based Conditioning Regimens.

Direct Intra-Bone Injection of Unrelated Cord Blood Cells Overcomes the Problem of Delayed Engraftment and Improves the Feasibility of Hematopoietic Transplant in Adult Patients.

Compared Molecular Monitoring of BCR-ABL Transcripts in Peripheral Blood and Bone Marrow Samples in CML Patients after Allogeneic Hematopoiteic Stem Cell Transplant.

Direct Intra-Bone Marrow Transplant of Cord Blood Cells: A Way To Overcome Delayed Engraftment.

Molecular Responders (<3-log Reduction) among CML Patients in Complete Cytogenetic Remission Show a Lower Number of BCR-ABL+ Hematopoietic Progenitors Compared to Non-Responders.

Rituximab Prophylaxis of EBV Reactivation after Unrelated Donor Transplants Using Anti-Thymocyte Globulin in the Conditioning Regimen.

The Persistence of p190 BCR-ABL Transcripts Is Associated with Lower Probability of Molecular Response to Imatinib in Early and Late Chronic Phase CML Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only